Prohost Biotech - Exclusive Biotech Research ~ A Comprehensive Resource for Biotech News

Imminent Announcements of Important Quarterly Results

October 28, 2020 0

Important Quarterly Results Announcements Monday, November 2, 2020 at 8:PM ET IVERIC bio IVERIC bio’s (ISEE) management team will host a live conference call and webcast following the announcement to discuss the Company’s financial results and provide a general business update. To participate in this conference call please dial 866-575-6539 (USA) or 323-794-2575 (International) using passcode 6339331. A live, listen-only, …

Tracking the News from AstraZeneca About Experimental Vaccine, AZD1222, for...

The U.S. FDA Approves Gilead Sciences Antiviral Veklury® (remdesivir) for...

Ionis Pharmaceuticals News About ALS Treatment Attempts

Tracking COVID-19 Vaccines

Enlivex Therapeutics Product AllocetraTM Saves Severe/Critical COVID-19 Patients

Gilead Sciences Could Acquire Immunomedics at $20 Billion. See Also:...

Sanofi and GlaxoSmithKLine COVID-19 Vaccines are Advancing in Clinical Trial

The U.S. CDC Tells the 50 States to Prepare for...

Kazia Therapeutics Product Paxalisib Beats Temozolomide in Overall Survival in...

Inovio: Good News About the Firm’s COVID-19 Vaccine’s Capability and...

TCR2 Therapeutics Encouraging Oncology Results

Jazz Pharmaceuticals: A New FDA Approval

INmune Bio: A Novel Approach Towards Treating Alzheimer’s Disease

Akero Therapeutics’ Product Efruxifermin Demonstrates Strong Positive Results in NASH...

Celldex Therapeutics: The Beginning of the Firm’s Resurrection

A Potential Merger Between AstraZeneca Plc and Gilead Sciences?

Navidea Biopharmaceuticals: Why This Small Firm’s Stock Skyrocketed

Moderna: Positive Interim Phase 1 Data for its mRNA-1273 Vaccine...

Sorrento Therapeutics: STI-1499 ~ An Encouraging Anti-SARS-CoV-2 Antibody

Impacting News

A Great Game Changer for the History of Biotechnology

October 20, 2020 0

Intellia Therapeutics Scientific Co-Founder Shares Nobel Prize in Chemistry with Collaborator On October 07, 2020 Jennifer …

Cytokinetics Product Omecamtiv Mecarbil for Heart Failure with Reduced Ejection Fraction

October 13, 2020 0

Cytokinetics Omecamtiv Mecarbil for Heat Failure Three biotech firms: Amgen (AMGN), Cytokinetics (

Filgotinib Has Become Great News for Gilead Sciences and Galapagos NV

October 12, 2020 0

Gilead and Galapagos Granted Marketing Authorization for Filgotinib by the EC Gilead Sciences (GILD) and Galapagos …

An Acquisition & a Collaboration You Must Know About

October 7, 2020 0

Bristol-Myers Squibb Increased activity being observed at Bristol-Myers Squibb (BMY) is aimed at further empowering the …

Johnson & Johnson Launches a Large Scale Phase 3 Trial of Its COVID-19 Vaccine. See Also: Intellia to Prove the Advantages of CRISPR Gene-Editing

September 29, 2020 0

Johnson & Johnson ENSEMBLE Trial for Its COVID-19 Vaccine Candidate Johnson & Johnson (JNJ) announced the …

Revolution Medicines Inc Has Revolutionary News

September 25, 2020 0

Revolution Medicines Inc Revolution Medicines (RVMD) is a clinical-stage precision oncology company focused on developing targeted …

Trick or Trade

SARS-CoV-2 Virus vs The President of the United States

October 5, 2020 0

President Trump, the First Lady and COVID-19 Indeed, the complicated, nasty SARS-CoV-2 virus managed to infect …

Sorrento Therapeutics Releases Preclinical Data from STI-1499 and STI-2020 Demonstrating Potent Neutralizing Antibodies Against SARS-CoV-2

September 29, 2020 0

Sorrento Therapeutics Preclinical Data of Neutralizing Antibodies Against SARS-CoV-2 In preclinical studies, both STI-1499 and STI-2020 …

Agenus: Could It Be a Resurrection? See Also: Prohost Performing Stocks

September 2, 2020 0

Agenus Announced Data from Phase 2 Trials of Balstilimab Agenus (AGEN) immuno-oncology company announced that data …

What’s Going on with Gene Therapy?

August 25, 2020 0

Recent Gene Therapy News On August 20, 2020 Audentes Therapeutics, which was taken over by Astellas …

The FDA’s Complete Response Letters, Creating Investment Opportunities?

August 20, 2020 0

Yesterday, under Today’s Highlights, we posted that the U.S. FDA issued a Complete Response Letter (CRL) …

An Important Announcement from Sorrento Therapeutics

August 13, 2020 0

Sorrento Therapeutics Announcement Sorrento Therapeutics (SRNE) announced that it believes it has uncovered fraudulent attempts to …

Today’s Highlights

Why We Expect a Lot from the Following Biotech Firms

October 27, 2020 0

Compugen Compugen (CGEN) announced the presentation of new research data that further support PVRIG as a potentially …

We Continue to Track the COVID-19 Vaccines. See Also: CRISPR Therapeutics Immuno-Oncology Results are Good.

October 21, 2020 0

The Latest on the COVID-19 Vaccines AstraZeneca (AZN): After pausing for more than a month, AZN …

Exelixis Has Good News Today and More is Expected

October 19, 2020 0

Exelixis and Bristol-Myers Squibb sNDA and sBLA Accepted by the FDA Exelixis (EXEL) and Bristol-Myers Squibb …

Celldex Therapeutics Doses the First Patient with its CDX-0159 Product for Chronic Spontaneous Urticaria

October 13, 2020 0

Celldex Therapeutics After an expected resurrection, Celldex Therapeutics (CLDX) stock recovered and went as high as …

Compugen Adds an Immuno-Oncology Pioneer to its Scientific Advisory Board. See Also: The New War Against Aging

October 8, 2020 0

Compugen New Addition, Dr. Nils Lonberg, PhD. Compugen (CGEN) announced the addition of Nils Lonberg, Ph.D., …

The FDA Lifted the Clinical Hold on Solid Biosciences’ IGNITE DMD Phase 1/2 Trial Sending the Stock Price Over 131%

October 1, 2020 0

Solid Biosciences Clinical Hold on IGNITE DMD is Lifted by the FDA Solid Biosciences (SLDB) - …

The Week in Review

Questions & Answers

May 27, 2020 0

The Week in Review #51 Questions & Answers About CytomX Q: Is there any reason for …

The World Focus is on COVID-19 Treatments and Vaccines

April 20, 2020 0

The Week in Review #50 The World FOCUS is COVID-19 The world FOCUS right now is …

Stars Before the Coronavirus Outbreak and Those Firms Treating COVID-19

March 24, 2020 0

The Week in Review #49 The Stars from the Weeks Preceding the Novel Coronavirus Outbreak Forty …

The Week in Review #48 ~ Holiday Edition

December 27, 2019 0

The Week in Review #48 Holiday Edition ******************** Merry Christmas and Happy Hanukkah! We Wish You …

What A Week For Biotechnology

November 11, 2019 0

The Week in Review #47 What A Week For Biotechnology Synopsis In this “Week in Review” …

The Quarterly Financial Results

November 4, 2019 0

The Week in Review #46 The Quarterly Financial Results The quarterly financial results that analysts and …

Prohost Letters

The Whole World Against the Blind SARS-CoV-2 Virus

September 28, 2020 3

Prohost Letter 442 The Whole World Against the Blind SARS-CoV-2 Virus Investors have no doubt profited …

Are We Saying Goodbye to Common Sense?

July 3, 2020 2

Prohost Letter #441 Biotechnology Companies’ Evaluations Are We Saying Goodbye to Common Sense? The SARS-CoV-2 Vaccines …

Novel Coronavirus: The Therapeutics

May 11, 2020 0

Prohost Letter #440 Coronavirus The Therapeutics Gilead’s Remdesivir Treating COVID-19 patients requires therapeutic products that can …

Prohost Letter #439

February 19, 2020 0

Prohost Letter #439 The Coronavirus Outbreak - COVID-19 The news announced that the coronavirus (now known …

Prohost Letter #438 ~ The End of the Year Issue 2019

January 1, 2020 0

Prohost Letter #438 End of the Year Issue 2019 Happy New Year 2020 The NASDAQ reached …

An All Time High Market

November 23, 2019 0

Prohost Letter #437 An All Time High Market More Prohost Picks Have Reached the 2019 Targets …